💊 New Molecule Approval Alert 💊 Stay updated with the latest approvals through Entvin AI! Drug Name: REVUFORJ NDA #: 218944 Active Ingredient: REVUMENIBREVUMENIB Company Name: Syndax Pharmaceuticals Submission Classification: Type 1 - New Molecular Entity Entvin AI ensures you never miss critical updates like this, helping you stay ahead in the ever-evolving pharma landscape. 💬 Schedule a call to learn more: https://lnkd.in/dkBjmhg5 Peter Ordentlich, Ariane Marolewski, Suniket Fulzele, Adi Kattuboina,
Entvin (YC S22)’s Post
More Relevant Posts
-
Lyophilization is a critical process in drug product development, essential for maintaining the stability and efficacy of pharmaceuticals. Coriolis Pharma specialises in optimising lyophilization processes to ensure consistent and high-quality results. In our upcoming webinar, you'll learn from experts Prof. Dr. Wolfgang Frieß and Dr. Brecht Vanbillemont as they present a comprehensive overview of lyophilization models, including robustness analysis. They'll cover simulating primary drying, predicting critical parameters, and performing in silico robustness analysis to assess the sensitivity of the lyophilization process to various conditions Register here > https://lnkd.in/e48b9spJ #Lyophilization #LyoModelling #CoriolisPharma #DrugDevelopment
-
-
Helping structural scientists to do their best work across drug discovery and design by giving computational chemists the tools and tips they need to discover drugs, develop materials, and break boundaries in science.
Thank you for sharing this valuable information! The insights on assessing the risk of polymorphism, evaluating interaction geometries, and rationalizing aromatic and H-bond interactions are incredibly useful for solid form scientists. These tools will undoubtedly help advance our work in tackling crucial challenges in pharmaceutical development. Looking forward to diving into the white paper! #Pharma #DrugDevelopment
Download our new white paper on the structural informatics tools developed by the Crystal Form Consortium (CFC) to tackle crucial pharmaceutical challenges. These tools help to: 💊 Assess the risk of polymorphism in solid forms 🔶 Evaluate the geometries of the existing interactions 💡 Rationalize aromatic and H-bond interactions 🔗https://lnkd.in/eWUy6EFr #Pharma #DrugDevelopment
-
-
Prof. Jerry Heng of Imperial College, UK, will be presenting “Peptide Crystallisation”, at the 5th Pharma Crystallization Summit in Session 1 - Crystallization of Complex Pharmaceutical Compounds. You can read the abstract and brief speaker bio at https://lnkd.in/gP664ZFt Please register now to secure your seat, https://lnkd.in/eubD65m3 We look forward to another exciting PCS with stimulating and fruitful sharing and discussions on the pressing topics in support of today’s new drug development. #PharmaCrystallizationSummit #DebottleneckingDrugDevelopment #ChallengingCrystallization #ParticleEngineering #ComputationTool
-
-
"Widened Scope of Drug Repurposing/Chiral Switches, Elements of Secondary Pharmaceuticals: The Quinine/Quinidine Case" This perspective article explores drug repurposing and chiral switches, focusing on the antimalarial quinine and the antiarrhythmic quinidine. It highlights how these drugs, with histories dating back to 1638, have been repurposed for new medical uses. Drug repurposing involves finding new applications for existing drugs, while chiral switches involve converting racemates to single enantiomers or other chiral forms. The article emphasizes the potential of the 16 stereoisomers of quinine/quinidine for new therapeutic uses and calls for comprehensive research in this area. Source: D’Acquarica, I., & Agranat, I. (2023). Future Drug Discovery, 5(3). https://lnkd.in/gT3rX9Tv; https://lnkd.in/gpp6EuRM #chiral_switch #drug_repurposing #secondary_pharmaceuticals #quinine_qunidine #cinchona_alkaloids #chiralpedia
-
-
Dr. Kuldeep Sharma Ph.D, MBA is highlighting how technology is revolutionizing impurity management in the pharmaceutical industry. He is addressing how user-friendly tech solutions are enhancing productivity and streamlining tasks at the 2nd Annual Pharma Impurity Conclave 2024. #ebmpic2024 #eminencebusinessmedia #eminencegroupventures
-
-
In this Pharmaceutical Commerce article by Suzanne Shelley, our experts Amanda Bruno and Angela Wlodar share the importance of using real-world data to inform patient-focused outreach. Read the full article: Combining RWE and AI to Bend the Adherence Curve (https://ow.ly/CwiU30sEczJ) #SyneosHealth
-
-
In this Pharmaceutical Commerce article by Suzanne Shelley, our experts Amanda Bruno and Angela Wlodar share the importance of using real-world data to inform patient-focused outreach. Read the full article: Combining RWE and AI to Bend the Adherence Curve (https://ow.ly/HCxI30sEknu) #SyneosHealth
-
-
💭 How can the pharmaceutical industry embrace process analytical technology? 📅 Join us on 24 April to find out... During this virtual panel discussion I'll be joined by Carrie Mason, Mark Milton, and Daniel Myatt who will: ✔️ share case studies on the use of PAT, including Raman, mid-IR and NMR 💡 advise on best practices for implementing PAT 🔮 discuss emerging PAT tools 🗺 explore the path to widespread adoption. There's still time to register using the link in the comments 👇 #PAT #pharma #biopharma #spectroscopy #Raman #NMR
-
-
Using #HELM (Hierarchical Editing Language for Macromolecules) to unlock the promise of complicated drug development is the future of effective, transparent communication in pharmaceutical R&D. Here's a look at the key benefits of HELM: http://ms.spr.ly/6048Wi2pj
-
Professor| Dean of Toxicological Research Center| Director of Clinical Toxicology Department, Loghman Hakim Hospital Poison Center| Editor in Chief toxir.com| Fellow of American College of Medical Toxicology
The latest research by us at Loghman Hakim Poison Center is published in DARU Journal of Pharmaceutical Sciences with impact factor4.3 .This study was designed to develop and evaluate machine learning algorithms for predicting the maintenance dose and duration of hospital stay in opioid poisoning, in order to facilitate appropriate clinical decision-making. You can read this article in DOI 10.1007/s40199-024-00518-x or 🔗 https://lnkd.in/dzd2FRWf
